Equities

Cellebrite DI Ltd

CLBT:NSQ

Cellebrite DI Ltd

Actions
TechnologyTechnology
  • Price (USD)17.39
  • Today's Change0.14 / 0.81%
  • Shares traded484.70k
  • 1 Year change+130.33%
  • Beta1.5199
Data delayed at least 15 minutes, as of Sep 19 2024 19:46 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments264139182
Total Receivables, Net838673
Total Inventory9.94106.51
Prepaid expenses8.897.818.93
Other current assets, total56533.06
Total current assets422296273
Property, plant & equipment, net303317
Goodwill, net272727
Intangibles, net111111
Long term investments2922--
Note receivable - long term------
Other long term assets7.341.731.96
Total assets533403340
LIABILITIES
Accounts payable8.284.619.55
Accrued expenses454543
Notes payable/short-term debt000
Current portion long-term debt/capital leases------
Other current liabilities, total200158135
Total current liabilities254208187
Total long term debt000
Total debt000
Deferred income tax------
Minority interest------
Other liabilities, total245122227
Total liabilities499329413
SHAREHOLDERS EQUITY
Common stock0.000.000
Additional paid-in capital(85)(126)(153)
Retained earnings (accumulated deficit)11819978
Treasury stock - common(0.09)(0.09)(0.09)
Unrealized gain (loss)------
Other equity, total1.050.331.37
Total equity3474(73)
Total liabilities & shareholders' equity533403340
Total common shares outstanding203193188
Treasury shares - common primary issue0.040.040.04
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.